278 related articles for article (PubMed ID: 25027708)
1. Expression and characterization of an M cell-specific ligand-fused dengue virus tetravalent epitope using Saccharomyces cerevisiae.
Nguyen NL; So KK; Kim JM; Kim SH; Jang YS; Yang MS; Kim DH
J Biosci Bioeng; 2015 Jan; 119(1):19-27. PubMed ID: 25027708
[TBL] [Abstract][Full Text] [Related]
2. Expression and purification of an immunogenic dengue virus epitope using a synthetic consensus sequence of envelope domain III and Saccharomyces cerevisiae.
Nguyen NL; Kim JM; Park JA; Park SM; Jang YS; Yang MS; Kim DH
Protein Expr Purif; 2013 Apr; 88(2):235-42. PubMed ID: 23376461
[TBL] [Abstract][Full Text] [Related]
3. Immunogenicity of a neutralizing epitope from porcine epidemic diarrhea virus: M cell targeting ligand fusion protein expressed in transgenic rice calli.
Huy NX; Kim SH; Yang MS; Kim TG
Plant Cell Rep; 2012 Oct; 31(10):1933-42. PubMed ID: 22736145
[TBL] [Abstract][Full Text] [Related]
4. M cell-targeting ligand and consensus dengue virus envelope protein domain III fusion protein production in transgenic rice calli.
Kim TG; Kim MY; Huy NX; Kim SH; Yang MS
Mol Biotechnol; 2013 Jul; 54(3):880-7. PubMed ID: 23250723
[TBL] [Abstract][Full Text] [Related]
5. Application of an M-cell-targeting ligand for oral vaccination induces efficient systemic and mucosal immune responses against a viral antigen.
Kim SH; Jung DI; Yang IY; Jang SH; Kim J; Truong TT; Pham TV; Truong NU; Lee KY; Jang YS
Int Immunol; 2013 Nov; 25(11):623-32. PubMed ID: 23900425
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of cell-surface displayed synthetic consensus dengue EDIII cells as a potent oral vaccine candidate.
Bal J; Jung HY; Nguyen LN; Park J; Jang YS; Kim DH
Microb Cell Fact; 2018 Sep; 17(1):146. PubMed ID: 30217208
[TBL] [Abstract][Full Text] [Related]
7. C5a receptor-targeting ligand-mediated delivery of dengue virus antigen to M cells evokes antigen-specific systemic and mucosal immune responses in oral immunization.
Kim SH; Yang IY; Jang SH; Kim J; Truong TT; Van Pham T; Truong NU; Lee KY; Jang YS
Microbes Infect; 2013 Nov; 15(13):895-902. PubMed ID: 23892099
[TBL] [Abstract][Full Text] [Related]
8. Production of dengue virus envelope protein domain III-based antigens in tobacco chloroplasts using inducible and constitutive expression systems.
Gottschamel J; Lössl A; Ruf S; Wang Y; Skaugen M; Bock R; Clarke JL
Plant Mol Biol; 2016 Jul; 91(4-5):497-512. PubMed ID: 27116001
[TBL] [Abstract][Full Text] [Related]
9. An adenovirus type 5 (AdV5) vector encoding an envelope domain III-based tetravalent antigen elicits immune responses against all four dengue viruses in the presence of prior AdV5 immunity.
Khanam S; Pilankatta R; Khanna N; Swaminathan S
Vaccine; 2009 Oct; 27(43):6011-21. PubMed ID: 19665609
[TBL] [Abstract][Full Text] [Related]
10. Virus-like particles displaying envelope domain III of dengue virus type 2 induce virus-specific antibody response in mice.
Arora U; Tyagi P; Swaminathan S; Khanna N
Vaccine; 2013 Jan; 31(6):873-8. PubMed ID: 23261049
[TBL] [Abstract][Full Text] [Related]
11. Induction of neutralizing antibodies and T cell responses by dengue virus type 2 envelope domain III encoded by plasmid and adenoviral vectors.
Khanam S; Khanna N; Swaminathan S
Vaccine; 2006 Oct; 24(42-43):6513-25. PubMed ID: 16860446
[TBL] [Abstract][Full Text] [Related]
12. [Mapping of the B Cell Neutralizing Epitopes on ED III of Envelope Protein from Dengue Virus].
Lin Y; Wen K; Guo Y; Qiu L; Pan Y; Yu L; Di B; Chen Y
Bing Du Xue Bao; 2015 Nov; 31(6):665-73. PubMed ID: 26951013
[TBL] [Abstract][Full Text] [Related]
13. Expression, refolding and bio-structural analysis of a tetravalent recombinant dengue envelope domain III protein for serological diagnosis.
Combe M; Lacoux X; Martinez J; Méjan O; Luciani F; Daniel S
Protein Expr Purif; 2017 May; 133():57-65. PubMed ID: 28274805
[TBL] [Abstract][Full Text] [Related]
14. An envelope domain III-based chimeric antigen produced in Pichia pastoris elicits neutralizing antibodies against all four dengue virus serotypes.
Etemad B; Batra G; Raut R; Dahiya S; Khanam S; Swaminathan S; Khanna N
Am J Trop Med Hyg; 2008 Sep; 79(3):353-63. PubMed ID: 18784226
[TBL] [Abstract][Full Text] [Related]
15. Dengue virus envelope domain III protein based on a tetravalent antigen secreted from insect cells: Potential use for serological diagnosis.
Niu G; Pang Z; Guan C; Qi J; Li D
Virus Res; 2015 Apr; 201():73-8. PubMed ID: 25697685
[TBL] [Abstract][Full Text] [Related]
16. Expression, purification and characterization of in vivo biotinylated dengue virus envelope domain III based tetravalent antigen.
Batra G; Talha SM; Nemani SK; Dhar N; Swaminathan S; Khanna N
Protein Expr Purif; 2010 Nov; 74(1):99-105. PubMed ID: 20435144
[TBL] [Abstract][Full Text] [Related]
17. Novel AAV-based genetic vaccines encoding truncated dengue virus envelope proteins elicit humoral immune responses in mice.
Li X; Cao H; Wang Q; Di B; Wang M; Lu J; Pan L; Yang L; Mei M; Pan X; Li G; Wang L
Microbes Infect; 2012 Sep; 14(11):1000-7. PubMed ID: 22626929
[TBL] [Abstract][Full Text] [Related]
18. Responses of primary human nasal epithelial cells to EDIII-DENV stimulation: the first step to intranasal dengue vaccination.
Nantachit N; Sunintaboon P; Ubol S
Virol J; 2016 Aug; 13():142. PubMed ID: 27538960
[TBL] [Abstract][Full Text] [Related]
19. Recombinant multiepitope protein for early detection of dengue infections.
Anandarao R; Swaminathan S; Fernando S; Jana AM; Khanna N
Clin Vaccine Immunol; 2006 Jan; 13(1):59-67. PubMed ID: 16426001
[TBL] [Abstract][Full Text] [Related]
20. Expression and assembly of cholera toxin B subunit and domain III of dengue virus 2 envelope fusion protein in transgenic potatoes.
Kim MY; Li JY; Tien NQ; Yang MS
Protein Expr Purif; 2017 Nov; 139():57-62. PubMed ID: 27335159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
